Your browser doesn't support javascript.
loading
Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.
Berretta, Massimiliano; Della Pepa, Chiara; Tralongo, Paolo; Fulvi, Alberto; Martellotta, Ferdinando; Lleshi, Arben; Nasti, Guglielmo; Fisichella, Rossella; Romano, Carmela; De Divitiis, Chiara; Taibi, Rosaria; Fiorica, Francesco; Di Francia, Raffaele; Di Mari, Anna; Del Pup, Lino; Crispo, Anna; De Paoli, Paolo; Santorelli, Adriano; Quagliariello, Vincenzo; Iaffaioli, Rosario Vincenzo; Tirelli, Umberto; Facchini, Gaetano.
Afiliación
  • Berretta M; Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy.
  • Della Pepa C; Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Tralongo P; Division of Medical Oncology, "Umberto I" Hospital, Syracuse, Italy.
  • Fulvi A; Department of Medicine and Surgery of Integrated Treatment, Division of Thoracic Oncology, "San Camillo Forlanini" Hospital, Rome, Italy.
  • Martellotta F; Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy.
  • Lleshi A; Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy.
  • Nasti G; Department of Abdominal Oncology, Division of Medical Oncology B, National Cancer Institute, "G. Pascale" Foundation, Naples, Italy.
  • Fisichella R; Department of Surgery, University of Catania, Catania, Italy.
  • Romano C; Department of Abdominal Oncology, Division of Medical Oncology B, National Cancer Institute, "G. Pascale" Foundation, Naples, Italy.
  • De Divitiis C; Department of Abdominal Oncology, Division of Medical Oncology B, National Cancer Institute, "G. Pascale" Foundation, Naples, Italy.
  • Taibi R; Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy.
  • Fiorica F; Department of Radiation Oncology University Hospital Ferrara, Division of Radiotherapy, "Arcispedale Sant'Anna" Hospital, Ferrara, Italy.
  • Di Francia R; Department of Hematology, Istituto Nazionale Tumori 'Fondazione Giovanni Pascale', IRCCS, Naples, Italy.
  • Di Mari A; Gruppo Oncologico Ricercatori Italiani, GORI, Pordenone, Italy.
  • Del Pup L; Division of Medical Oncology, "Umberto I" Hospital, Syracuse, Italy.
  • Crispo A; Division of Gynaecological Oncology, National Cancer Institute, Aviano (PN), Italy.
  • De Paoli P; Unit of Epidemiology, Struttura Complessa di Statistica Medica, Biometria e Bioinformatica, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Santorelli A; Scientific Directorate, National Cancer Institute, Aviano (PN), Italy.
  • Quagliariello V; Department of Plastic Surgery, Regenerative Medicine, Health Park Hospital, Naples, Italy.
  • Iaffaioli RV; Department of Abdominal Oncology, Division of Medical Oncology B, National Cancer Institute, "G. Pascale" Foundation, Naples, Italy.
  • Tirelli U; Department of Abdominal Oncology, Division of Medical Oncology B, National Cancer Institute, "G. Pascale" Foundation, Naples, Italy.
  • Facchini G; Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy.
Oncotarget ; 8(15): 24401-24414, 2017 Apr 11.
Article en En | MEDLINE | ID: mdl-28212560
ABSTRACT

INTRODUCTION:

Complementary and Alternative Medicine (CAM) include a wide range of products (herbs, vitamins, minerals, and probiotics) and medical practices, developed outside of the mainstream Western medicine. Patients with cancer are more likely to resort to CAM first or then in their disease history; the potential side effects as well as the costs of such practices are largely underestimated. PATIENTS AND

METHOD:

We conducted a descriptive survey in five Italian hospitals involving 468 patients with different malignancies. The survey consisted of a forty-two question questionnaire, patients were eligible if they were Italian-speaking and receiving an anticancer treatment at the time of the survey or had received an anticancer treatment no more than three years before participating in the survey.

RESULTS:

Of our patients, 48.9% said they use or have recently used CAM. The univariate analysis showed that female gender, high education, receiving treatment in a highly specialized institute and receiving chemotherapy are associated with CAM use; at the multivariate analysis high education (Odds Ratio, (OR) 1.96 95% Confidence Interval, CI, 1.27-3.05) and receiving treatment in a specialized cancer center (OR 2.75 95% CI, 1.53-4.94) were confirmed as risk factors for CAM use.

CONCLUSION:

Roughly half of our patients receiving treatment for cancer use CAM. It is necessary that health professional explore the use of CAM with their cancer patients, educate them about potentially beneficial therapies in light of the limited available evidence of effectiveness, and work towards an integrated model of health-care provision.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapias Complementarias / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapias Complementarias / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia